Covered recipient · General Payments record
PETER K KWOFIE
Allopathic & Osteopathic Physicians Internal Medicine Infectious Disease
General Payments · PY2018–2024
$3,345.10
- Reported across 189 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $215.72 | 13 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $44.94 | 3 |
| Acerta Pharma LLC | $32.44 | 2 |
| Lilly USA, LLC | $31.43 | 2 |
| Abbott Laboratories | $23.39 | 1 |
| ABBVIE INC. | $20.23 | 1 |
| GlaxoSmithKline, LLC. | $17.30 | 1 |
| Paratek Pharmaceuticals, Inc. | $17.22 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $15.17 | 1 |
| PFIZER INC. | $13.60 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (13)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $23.39 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124854511 | CMS |
| ABBVIE INC. | $20.23 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104123650 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.21 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105847023 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.23 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104673071 | CMS |
| GlaxoSmithKline, LLC. | $17.30 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116619785 | CMS |
| Lilly USA, LLC | $16.68 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135323094 | CMS |
| Lilly USA, LLC | $14.75 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135316995 | CMS |
| Novartis Pharmaceuticals Corporation | $15.17 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087137722 | CMS |
| Novo Nordisk Inc | $14.77 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096688086 | CMS |
| Novo Nordisk Inc | $14.80 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097681304 | CMS |
| Novo Nordisk Inc | $15.37 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097362104 | CMS |
| Paratek Pharmaceuticals, Inc. | $17.22 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113907087 | CMS |
| PFIZER INC. | $13.60 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131717822 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.